✦ LIBER ✦

An Artificial Neural Network for Prostate Cancer Staging when Serum Prostate Specific Antigen is 10 NG./ML. or Less

✍ Scribed by ZLOTTA, A; REMZI, M; SNOW, P; SCHULMAN, C; MARBERGER, M; DJAVAN, B

Book ID: 122397184
Publisher: Lippincott Williams and Wilkins
Year: 2003
Tongue: English
Weight: 140 KB
Volume: 169
Category: Article
ISSN: 0022-5347
DOI: 10.1097/01.ju.0000062548.28015.f6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum-to-Urinary Prostate Specific Antig

Serum-to-Urinary Prostate Specific Antigen Ratio: Its Impact in Distinguishing Prostate Cancer When Serum Prostate Specific Antigen Level is 4 to 10 ng./ml.

✍ Irani, Jacques; Millet, Christine; Levillain, Pierre; Dore, Bertrand; Begon, Fra 📂 Article 📅 1997 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 463 KB

PROSTATE SPECIFIC ANTIGEN DENSITY OF THE

PROSTATE SPECIFIC ANTIGEN DENSITY OF THE TRANSITION ZONE FOR PREDICTING PATHOLOGICAL STAGE OF LOCALIZED PROSTATE CANCER IN PATIENTS WITH SERUM PROSTATE SPECIFIC ANTIGEN LESS THAN 10 NG./ML.

✍ ZLOTTA, A.R.; DJAVAN, B.; PETEIN, M.; SUSANI, M.; MARBERGER, M.; SCHULMAN, C.C. 📂 Article 📅 1998 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 759 KB

Prostate-specific antigen nadir of 0.5 n

Prostate-specific antigen nadir of 0.5 ng/ml or less defines disease freedom for surgically staged men irradiated for prostate cancer

✍ Frank A. Critz; Keith Levinson; W. Hamilton Williams; David Holladay; Clinton Ho 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 491 KB

UP-1.116: Total Prostate Volume is an Ef

UP-1.116: Total Prostate Volume is an Effective Predictor of Cancer Detection with Serum Prostate Specific Antigen between 4.0 and 10.0 ng/Ml in Macau SAR

✍ L. Ian; H. Lao; S. Ho; W. Pun; K. Li; M. Tse 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Use of percentage of free prostate-speci

Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when psa levels are 2.51 to 4 ng/mL and digital rectal examination is not suspicious for prostate cancer: an alternative model

✍ William J Catalona; Alan W Partin; Judith A Finlay; Daniel W Chan; Harry G Ritte 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 158 KB